UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Annual Report to the Nation on the Status of Cancer, 1975―2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)―Associated Cancers and HPV Vaccination Coverage Levels

JNCI : Journal of the National Cancer Institute, 2013-02, Vol.105 (3), p.175-201

2013

Volltextzugriff (PDF)

Human Papillomavirus–Associated Cancers — United States, 2008–2012

MMWR. Morbidity and mortality weekly report, 2016-07, Vol.65 (26), p.661-666

2016

Volltextzugriff (PDF)

Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011

MMWR. Morbidity and mortality weekly report, 2011-12, Vol.60 (50), p.1705-1708

2011

Volltextzugriff (PDF)

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

MMWR. Recommendations and reports, 2007-03, Vol.56 (RR-2), p.1-23

2007

Volltextzugriff (PDF)

Comparison of Methods for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Using Commercially Available Nucleic Acid Amplification Tests and a Liquid Pap Smear Medium

Journal of Clinical Microbiology, 2003-04, Vol.41 (4), p.1507-1511

2003

Volltextzugriff (PDF)

Reply to Groner et al and Pei et al

The Journal of infectious diseases, 2014-04, Vol.209 (8), p.1304-1305

2014

Volltextzugriff (PDF)

National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023

MMWR. Morbidity and mortality weekly report, 2024-08, Vol.73 (33), p.708-714

2024

Volltextzugriff (PDF)

TPrevalence of HPV in Adults Aged 18-69: United States, 2011-2014

NCHS data brief, 2017-04 (280), p.1-8

2017

Volltextzugriff (PDF)

Adult Vaccination Coverage — United States, 2010

MMWR. Morbidity and mortality weekly report, 2012-02, Vol.61 (4), p.66-72

2012

Volltextzugriff (PDF)

HPV AND ORAL HEALTH: Response from Dr. Cleve-land and colleagues

The Journal of the American Dental Association (1939), 2012-05, Vol.143 (5), p.440-442

2012

Volltextzugriff (PDF)

The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States

The Journal of the American Dental Association (1939), 2011-08, Vol.142 (8), p.915-924

2011

Volltextzugriff (PDF)

Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling

Journal of the National Cancer Institute. Monographs, 2024-11, Vol.2024 (67), p.387-399

2024

Volltextzugriff (PDF)

Vaccine effectiveness against anal HPV among men who have sex with men aged 18-45 years attending sexual health clinics in three United States cities, 2018-2023

The Journal of infectious diseases, 2024-08

2024

Volltextzugriff (PDF)

Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination

Journal of the National Cancer Institute. Monographs, 2024-11, Vol.2024 (67), p.346-357

2024

Volltextzugriff (PDF)

Screening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections — 2002

MMWR. Recommendations and reports, 2002-10, Vol.51 (RR-15), p.1-38

2002

Volltextzugriff (PDF)

Progress Toward Implementation of Human Papillomavirus Vaccination — the Americas, 2006–2010

MMWR. Morbidity and mortality weekly report, 2011-10, Vol.60 (40), p.1382-1384

2011

Volltextzugriff (PDF)

Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.215-215.18

2016

Volltextzugriff (PDF)

Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following HPV Vaccine Introduction in the United States

Clinical infectious diseases, 2021-02

2021

Volltextzugriff (PDF)

Health and Economic Impact of Switching From a 4-Valent to a 9-Valent HPV Vaccination Program in the United States

JNCI : Journal of the National Cancer Institute, 2016-01, Vol.108 (1), p.1

2016

Volltextzugriff (PDF)

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S738-S738

2018

Volltextzugriff (PDF)

Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003–2006: Table 1

Sexually transmitted infections, 2014-09, Vol.90 (6), p.505-508

2014

Volltextzugriff (PDF)

Immunization of Six-Month-Old Infants with Different Doses of Edmonston–Zagreb and Schwarz Measles Vaccines

The New England journal of medicine, 1990-03, Vol.322 (9), p.580-587

1990

Volltextzugriff (PDF)

Updates on Human Papillomavirus and Genital Warts and Counseling Messages From the 2010 Sexually Transmitted Diseases Treatment Guidelines: Sexually Transmitted Disease Treatment Guidelines

Clinical infectious diseases, 2011, Vol.53

2011

Volltextzugriff (PDF)

Emerging Infections: Genital Human Papillomavirus Infection

Clinical infectious diseases, 2006-09, Vol.43 (5), p.624-629

2006

Volltextzugriff (PDF)

Response from Dr. Cleveland and colleagues

The Journal of the American Dental Association (1939), 2012-05, Vol.143 (5), p.440

2012

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

KollektionWiley Online Library

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Annual Report to the Nation on the Status of Cancer, 1975―2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)―Associated Cancers and HPV Vaccination Coverage Levels

Human Papillomavirus–Associated Cancers — United States, 2008–2012

Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Comparison of Methods for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Using Commercially Available Nucleic Acid Amplification Tests and a Liquid Pap Smear Medium

Reply to Groner et al and Pei et al

National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023

TPrevalence of HPV in Adults Aged 18-69: United States, 2011-2014

Adult Vaccination Coverage — United States, 2010

HPV AND ORAL HEALTH: Response from Dr. Cleve-land and colleagues

The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States

Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling

Vaccine effectiveness against anal HPV among men who have sex with men aged 18-45 years attending sexual health clinics in three United States cities, 2018-2023

Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination

Screening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections — 2002

Progress Toward Implementation of Human Papillomavirus Vaccination — the Americas, 2006–2010

Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity

Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following HPV Vaccine Introduction in the United States

Health and Economic Impact of Switching From a 4-Valent to a 9-Valent HPV Vaccination Program in the United States

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017

Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003–2006: Table 1

Immunization of Six-Month-Old Infants with Different Doses of Edmonston–Zagreb and Schwarz Measles Vaccines

Updates on Human Papillomavirus and Genital Warts and Counseling Messages From the 2010 Sexually Transmitted Diseases Treatment Guidelines: Sexually Transmitted Disease Treatment Guidelines

Emerging Infections: Genital Human Papillomavirus Infection

Response from Dr. Cleveland and colleagues

Aktive Filter

Suchergebnisse filtern